Delivery Order SPE2DB24D2101-SPE2DB25FKLUV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Metoprolol Succinate Extended Release 25 mg tablets in quantities of 1,000 units. This firm fixed-price delivery order, valued at $1,542.30, represents a non-competitive set-aside contract and is scheduled for completion by August 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of 1,000 tablets of Metoprolol Succinate Extended Release 50 mg, with a contract ceiling value of $4,081.00 and completion deadline of September 11, 2025. This is a firm fixed-price delivery order issued without set-aside restrictions, meaning it was competitively awarded. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Metoprolol Succinate Extended Release 50 mg, valued at $1,312.12. This competitively awarded, firm fixed-price delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The products will be delivered to Conshohocken, Pennsylvania, the company's headquarters location. This delivery order is issued under AmerisourceBergen Drug Corp's...
- This is a $1,785.84 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for Metoprolol Succinate Extended-Release 25 mg tablets, with an ultimate completion date of June 10, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,486.08 to AmerisourceBergen Drug Corp for the supply of Metoprolol Succinate ER 50 mg tablets (1,000 count) on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order represents a non-competitive contract award with place of performance in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The contract falls under AmerisourceBergen Drug Corp's...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 1,000 units of the medication Metoprolol Succinate Extended-Release 25 mg tablets. The contract has a ceiling value of $1,002.04 and is a firm fixed-price delivery order, meaning the price is set and will not change. It is not designated as a set-aside...
- The Defense Logistics Agency awarded a $4,989.36 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of 1,000 tablets of Metoprolol Succinate ER 100 mg. The contract is scheduled for ultimate completion on August 8, 2025, and represents a non-set-aside competitive award. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending...
- The Defense Logistics Agency (DLA) awarded a $1,567.42 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for 4,565,220 units of Metoprolol Succinate Extended-Release 50mg tablets. This delivery order is part of a larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range of critical medical commodities,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,000 units of the drug Metoprolol Succinate Extended-Release 50 mg tablets. The contract has a firm fixed price of $2,768.80 and a completion date of July 2, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. This contract is part of a larger...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,076.75 firm fixed-price contract is for the delivery of 4,564,542,315 units of Metoprolol Succinate ER 50 mg tablets. The contract has an ultimate completion date of May 9, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKLUVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of Metoprolol Succinate Extended Release 50 mg tablets in a quantity of 1,000 units, with a ceiling value of $1,190.86. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract is set to be completed by June 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications and medical supplies to support military healthcare programs worldwide. The Metoprolol Succinate order represents a routine pharmaceutical fulfillment under this strategic vendor relationship, supporting the Defense Health Agency and other federal healthcare systems with essential cardiac medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/26/25 |